Disclosures for "Treatment with rhFGF18 Analog Results in Cerebroprotection and Recovery of Motor and Memory Function in a Rat Model of Acute Ischemic Stroke")
-
Mr. Goraltchouk has received personal compensation for serving as an employee of Remedium Bio, Inc.
-
Mr. Luppino has received personal compensation for serving as an employee of Remedium Bio. Mr. Luppino has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anika Therapeutics. Mr. Luppino has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Remedium Bio. Mr. Luppino has stock in Remedium Bio. Mr. Luppino has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Seregin has received personal compensation for serving as an employee of Remedium Bio. Dr. Seregin has stock in Remedium Bio.